← Back to Clinical Trials
Recruiting NCT06619626

NCT06619626 Alveolar Recruitment in Obese Patients in Major Gynaecological Cancer Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06619626
Status Recruiting
Phase
Sponsor Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Condition Gynecologic Cancers
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-01-01
Primary Completion 2024-11-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
alveolar recruitment strategy applied groupgroup without alveolar recruitment strategy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-01-01 with a primary completion date of 2024-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this study, the investigators planned to evaluate the effect of alveolar recruitment strategy primarily on postoperative pulmonary complications in obese patients undergoing lung protective ventilation in major open gynaeco-oncological surgeries. Our other aim was to evaluate perioperative haemodynamics, respiratory mechanics,inpatient length of stay.

Eligibility Criteria

Inclusion Criteria: * Patients with ASAII and III * BMI\>30 kg/m2 ,\<40 kg/m2 * Patients with an ARISCAT risk score of 26-44 Exclusion Criteria: * Patients with an Assessment of Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) risk score \> 44 * BMI \> 40 kg/m2 patients

Contact & Investigator

Central Contact

Duygu Akyol

✉ dr.duyguaygun@gmail.com

📞 +905447616034

Principal Investigator

Duygu Akyol

PRINCIPAL INVESTIGATOR

Başakşehir Çam & Sakura City Hospital

Frequently Asked Questions

Who can join the NCT06619626 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06619626 currently recruiting?

Yes, NCT06619626 is actively recruiting participants. Contact the research team at dr.duyguaygun@gmail.com for enrollment information.

Where is the NCT06619626 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06619626 clinical trial?

NCT06619626 is sponsored by Bakirkoy Dr. Sadi Konuk Research and Training Hospital. The principal investigator is Duygu Akyol at Başakşehir Çam & Sakura City Hospital. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology